Dansey Roger D's Form 4 filing
Seagen Inc. (SGEN) · filed Jan 5, 2022
- Accession no.
- 0001203311-22-000002
- Filed
- Jan 5, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dansey Roger DCIK 0001741836 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | SSaleDisposed | −3,470 | $152.58 | −$529,452.6 | 84,891 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −3,470 | $152.58 | −$529,452.6 | 81,421 | Direct | |
| Jan 3, 2022 | Common Stock | SSaleDisposed | −1,735 | $152.58 | −$264,726.3 | 79,686 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.